AU2001237016A1 - In ovo protection against infectious bronchitis - Google Patents

In ovo protection against infectious bronchitis

Info

Publication number
AU2001237016A1
AU2001237016A1 AU2001237016A AU3701601A AU2001237016A1 AU 2001237016 A1 AU2001237016 A1 AU 2001237016A1 AU 2001237016 A AU2001237016 A AU 2001237016A AU 3701601 A AU3701601 A AU 3701601A AU 2001237016 A1 AU2001237016 A1 AU 2001237016A1
Authority
AU
Australia
Prior art keywords
vaccine
immunogenically
effective amount
chicken
ovo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237016A
Other languages
English (en)
Inventor
Frans G. Davelaar
Berend Jongsma
Marinus Wijnand Weststrate
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/775,750 external-priority patent/US20010046500A1/en
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU2001237016A1 publication Critical patent/AU2001237016A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU2001237016A 2000-02-29 2001-02-15 In ovo protection against infectious bronchitis Abandoned AU2001237016A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US51573200A 2000-02-29 2000-02-29
US09515732 2000-02-29
US09775750 2001-02-02
US09/775,750 US20010046500A1 (en) 2000-02-29 2001-02-02 In ovo protection against infectious bronchitis
PCT/US2001/004792 WO2001064244A2 (fr) 2000-02-29 2001-02-15 Protection in ovo contre la bronchite infectieuse

Publications (1)

Publication Number Publication Date
AU2001237016A1 true AU2001237016A1 (en) 2001-09-12

Family

ID=27058588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237016A Abandoned AU2001237016A1 (en) 2000-02-29 2001-02-15 In ovo protection against infectious bronchitis

Country Status (20)

Country Link
EP (2) EP1259257B1 (fr)
JP (1) JP2003529565A (fr)
CN (1) CN1406135A (fr)
AR (1) AR027558A1 (fr)
AT (1) ATE463253T1 (fr)
AU (1) AU2001237016A1 (fr)
BR (1) BR0108735A (fr)
CA (1) CA2401145A1 (fr)
CY (1) CY1110544T1 (fr)
DE (1) DE60141743D1 (fr)
DK (1) DK1259257T3 (fr)
ES (1) ES2341841T3 (fr)
IL (1) IL151039A0 (fr)
MX (1) MXPA02008254A (fr)
NO (1) NO20024100L (fr)
NZ (1) NZ520761A (fr)
PL (1) PL365447A1 (fr)
PT (1) PT1259257E (fr)
WO (1) WO2001064244A2 (fr)
YU (1) YU65102A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR031405A1 (es) 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
WO2004078203A2 (fr) * 2003-03-03 2004-09-16 Akzo Nobel N.V. Virus de la bronchite infectieuse comprenant un gene additif modifie
WO2007072916A1 (fr) * 2005-12-22 2007-06-28 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Vaccin pour inoculation in ovo
CN109641043A (zh) 2016-06-16 2019-04-16 勃林格殷格翰动物保健有限公司 针对感染性支气管炎病毒的疫苗
CN112996537A (zh) 2018-10-31 2021-06-18 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的4/91 ibv疫苗
CN112996536A (zh) 2018-10-31 2021-06-18 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的h52 ibv疫苗
CN114126645A (zh) 2019-05-10 2022-03-01 勃林格殷格翰动物保健有限公司 冠状病毒刺突蛋白的修饰的s1亚基
US20220213148A1 (en) 2019-05-10 2022-07-07 Boehringer Ingelheim Vetmedica Gmbh Modified s2 subunit of the coronavirus spike protein
MX2021013728A (es) 2019-05-10 2021-12-10 Boehringer Ingelheim Vetmedica Gmbh Ibv atenuado con tropismo de cultivo celular y tisular extendido.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE196773T1 (de) * 1993-07-30 2000-10-15 Akzo Nobel Nv Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
US6506385B1 (en) * 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith

Also Published As

Publication number Publication date
EP2198883A1 (fr) 2010-06-23
AR027558A1 (es) 2003-04-02
PT1259257E (pt) 2010-06-01
WO2001064244A2 (fr) 2001-09-07
JP2003529565A (ja) 2003-10-07
CA2401145A1 (fr) 2001-09-07
NO20024100D0 (no) 2002-08-28
IL151039A0 (en) 2003-04-10
MXPA02008254A (es) 2003-02-06
CY1110544T1 (el) 2015-04-29
EP1259257A2 (fr) 2002-11-27
EP1259257B1 (fr) 2010-04-07
WO2001064244A3 (fr) 2002-01-31
PL365447A1 (en) 2005-01-10
DE60141743D1 (de) 2010-05-20
BR0108735A (pt) 2002-12-17
YU65102A (sh) 2005-09-19
ATE463253T1 (de) 2010-04-15
DK1259257T3 (da) 2010-06-14
NO20024100L (no) 2002-10-09
CN1406135A (zh) 2003-03-26
NZ520761A (en) 2004-10-29
ES2341841T3 (es) 2010-06-29

Similar Documents

Publication Publication Date Title
EP1259257B1 (fr) Protection in ovo contre la bronchite infectieuse
JPS63307828A (ja) ニューカッスル病ウイルスワクチン及びその適用方法
CA2273074C (fr) Vaccination in ovo contre la maladie de newcastle
US7208164B2 (en) Ovo immunization against infectious bronchitis
RU2542440C2 (ru) Живая вакцина против заболеваний птиц
US7348012B2 (en) Methods and vaccines for providing in ovo protection against turkey rhinotracheitis
HU203674B (en) Process for producing weakened turtle rhinotracheitis virus and vaccine containing them
Calnek et al. Committee report on a tentative program for the control of avian encephalomyelitis
ZA200207756B (en) In ovo protection against infectious bronchitis.
Raheem et al. Continental Veterinary Journal
AU2002243426A1 (en) Methods and vaccines for providing in ovo protection against turkey rhinotracheitis
van Eck Protection of broilers against Newcastle disease by hyperimmunisation of the dams
KR20220041142A (ko) 조류에 점막 투여하기 위한 조성물
Cutler Vaccines and vaccination
Jaber et al. Comparative efficacy of fowl cholera vaccines in ducks
EL-MAKAKY et al. TRIALS FOR PREPARATION OF INACTIVATED BIVALENT AVIAN ENCEPHALOMYELITIS AND REO VIRUS VACCINE
Mugera Respiratory Diseases of Poultry and Their Control
Rivera-Cruz Some immunological aspects of Newcastle disease virus.